ATC codes: L01DB01
Burkitt lymphoma including Burkitt leukaemia ICD11 code: 2B55.6
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) ; 50 mg in vial (hydrochloride)
Also recommended for children
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for doxorubicin on the complementary list of the EML and EMLc for use in treatment protocols for Burkitt lymphoma was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for Burkitt lymphoma is attached.